23 patents currently held
169 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Oct 2027. from the record
Of the 169 now held by other companies, 165 name LivaNova USA Inc. as their current owner, and 4 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
12
Ending by 2030
Oct 2027
Next term end
10
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jan 2028 · High confidence
Also notable
Ends Dec 2028 · High confidence
Also notable
Ends Feb 2031 · High confidence
Obstructive Sleep Apnea Treatment Devices, Systems and Methods
US 7,809,442
The most cited patent in this portfolio, cited by 484 later US patents, top 1% of utility patents granted in 2010 in our data. Protection runs to 2028.
Implantable Systems and Methods for Identifying a Contra-Ictal Condition in a Subject
US 8,036,736
Cited by 189 later US patents, top 5% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
Method, Apparatus and System for Validating and Quantifying Cardiac Beat Data Quality
US 8,831,732
Cited by 45 later US patents, top 25% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
Formerly held, still cited
Notable
Ends Sep 2031 · High confidence
Cited by 176 later US patents, top 1% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
now held by LivaNova USA, Inc.
Also notable
Ends Jun 2031 · High confidence
Cited by 128 later US patents, top 5% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
now held by LivaNova USA, Inc.
Also notable
Ends May 2030 · High confidence
Cited by 296 later US patents, top 5% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
now held by LivaNova USA, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Aug 16, 2027The maintenance fee for Housing for an Implantable Medical Device (US 9,259,591) comes due Aug 16, 2027. Unpaid by Feb 16, 2028, it lapses early.
- 1 fee due Sep 22, 2027The maintenance fee for Medical Lead Termination Sleeve for Implantable Medical Devices (US 9,289,595) comes due Sep 22, 2027. Unpaid by Mar 22, 2028, it lapses early.
Recent changes
- 7 terms have ended since Aug 16, 2026
What they patent
The 5 largest of its 10 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Obstructive Sleep Apnea Treatment Devices, Systems and Methods | 11 in force | to Mar 2032 |
| Medical Lead Termination Sleeve for Implantable Medical Devices | 2 in force | to Oct 2031 |
| Method, Apparatus and System for Validating and Quantifying Cardiac Beat Data Quality | 2 in force | to Feb 2031 |
| Implantable Systems and Methods for Identifying a Contra-Ictal Condition in a Subject | 2 in force | to Dec 2028 |
| Communication Error Alerting in an Epilepsy Monitoring System | 1 in force | to Jul 2030 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,311,645 | Obstructive Sleep Apnea Treatment Devices, Systems and Methods In force · High confidence | In force | High confidence | |
| US 8,498,712 | Obstructive Sleep Apnea Treatment Devices, Systems and Methods In force · High confidence | In force | High confidence | |
| US 8,626,304 | Obstructive Sleep Apnea Treatment Devices, Systems and Methods In force · High confidence | In force | High confidence | |
| US 8,639,354 | Obstructive Sleep Apnea Treatment Devices, Systems and Methods In force · High confidence | In force | High confidence | |
| US 8,718,783 | Obstructive Sleep Apnea Treatment Devices, Systems and Methods In force · High confidence | In force | High confidence | |
| US 7,809,442 | Obstructive Sleep Apnea Treatment Devices, Systems and Methods In force · High confidence | In force | High confidence | |
| US 8,543,199 | Implantable Systems and Methods for Identifying a Contra-ictal Condition in a Subject In force · High confidence | In force | High confidence | |
| US 8,744,589 | Obstructive Sleep Apnea Treatment Devices, Systems and Methods In force · High confidence | In force | High confidence | |
| US 8,036,736 | Implantable Systems and Methods for Identifying a Contra-Ictal Condition in a Subject In force · High confidence | In force | High confidence | |
| US 9,259,591 | Housing for an Implantable Medical Device In force · High confidence | In force | High confidence |
Also on record, not counted in the 23: 169 patents in force now held by others · 95 patents ended · 2 applications pending · 65 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.